These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 14970020)
1. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020 [TBL] [Abstract][Full Text] [Related]
2. Cerebral blood volume measurements by perfusion-weighted MR imaging in gliomas: ready for prime time in predicting short-term outcome and recurrent disease? Bisdas S; Kirkpatrick M; Giglio P; Welsh C; Spampinato MV; Rumboldt Z AJNR Am J Neuroradiol; 2009 Apr; 30(4):681-8. PubMed ID: 19179427 [TBL] [Abstract][Full Text] [Related]
3. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878 [TBL] [Abstract][Full Text] [Related]
4. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [TBL] [Abstract][Full Text] [Related]
5. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. Sugahara T; Korogi Y; Kochi M; Ushio Y; Takahashi M AJNR Am J Neuroradiol; 2001 Aug; 22(7):1306-15. PubMed ID: 11498419 [TBL] [Abstract][Full Text] [Related]
6. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Zonari P; Baraldi P; Crisi G Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871 [TBL] [Abstract][Full Text] [Related]
7. Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas. Spampinato MV; Schiarelli C; Cianfoni A; Giglio P; Welsh CT; Bisdas S; Rumboldt Z Neuroradiol J; 2013 Aug; 26(4):385-95. PubMed ID: 24007727 [TBL] [Abstract][Full Text] [Related]
8. Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading. Kim H; Choi SH; Kim JH; Ryoo I; Kim SC; Yeom JA; Shin H; Jung SC; Lee AL; Yun TJ; Park CK; Sohn CH; Park SH PLoS One; 2013; 8(5):e63462. PubMed ID: 23704910 [TBL] [Abstract][Full Text] [Related]
9. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. Preul C; Kühn B; Lang EW; Mehdorn HM; Heller M; Link J Eur J Radiol; 2003 Dec; 48(3):244-51. PubMed ID: 14652141 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. Schmainda KM; Rand SD; Joseph AM; Lund R; Ward BD; Pathak AP; Ulmer JL; Badruddoja MA; Krouwer HG AJNR Am J Neuroradiol; 2004 Oct; 25(9):1524-32. PubMed ID: 15502131 [TBL] [Abstract][Full Text] [Related]
11. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas. Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628 [TBL] [Abstract][Full Text] [Related]
12. Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach. Latysheva A; Emblem KE; Brandal P; Vik-Mo EO; Pahnke J; Røysland K; Hald JK; Server A Neuroradiology; 2019 May; 61(5):545-555. PubMed ID: 30712139 [TBL] [Abstract][Full Text] [Related]
13. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. Emblem KE; Scheie D; Due-Tonnessen P; Nedregaard B; Nome T; Hald JK; Beiske K; Meling TR; Bjornerud A AJNR Am J Neuroradiol; 2008 Oct; 29(9):1664-70. PubMed ID: 18583405 [TBL] [Abstract][Full Text] [Related]
14. Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes. Mangla R; Ginat DT; Kamalian S; Milano MT; Korones DN; Walter KA; Ekholm S J Neurooncol; 2014 Jan; 116(2):325-31. PubMed ID: 24178441 [TBL] [Abstract][Full Text] [Related]
15. Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Di Costanzo A; Pollice S; Trojsi F; Giannatempo GM; Popolizio T; Canalis L; Armillotta M; Maggialetti A; Carriero A; Tedeschi G; Scarabino T Radiol Med; 2008 Feb; 113(1):134-43. PubMed ID: 18338133 [TBL] [Abstract][Full Text] [Related]
16. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging. Sunwoo L; Choi SH; Yoo RE; Kang KM; Yun TJ; Kim TM; Lee SH; Park CK; Kim JH; Park SW; Sohn CH; Won JK; Park SH; Kim IH Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204 [TBL] [Abstract][Full Text] [Related]
17. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838 [TBL] [Abstract][Full Text] [Related]
18. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107 [TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation. Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. Cha S; Tihan T; Crawford F; Fischbein NJ; Chang S; Bollen A; Nelson SJ; Prados M; Berger MS; Dillon WP AJNR Am J Neuroradiol; 2005 Feb; 26(2):266-73. PubMed ID: 15709123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]